Global Gastroesophageal Reflux Disease Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 174309
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Gastroesophageal Reflux Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastroesophageal Reflux Disease Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Gastroesophageal Reflux Disease Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Gastroesophageal Reflux Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Antacids

H2 Receptor Blockers

Proton Pump Inhibitors (PPIs)

Pro-kinetic Agents

Others

Market segment by Application, can be divided into

Hospital Pharmacy

Drug Stores

General Stores

Supermarkets

Market segment by players, this report covers

AstraZeneca

Eisai

Takeda Pharmaceutical

GlaxoSmithKline

Johnson & Johnson

Daewoong Pharmaceutical

Ironwood Pharmaceuticals

Rottapharm Madaus

Peer Medical

Reviva Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gastroesophageal Reflux Disease Therapeutics

1.2 Classification of Gastroesophageal Reflux Disease Therapeutics by Type

1.2.1 Overview: Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type in 2020

1.2.3 Antacids

1.2.4 H2 Receptor Blockers

1.2.5 Proton Pump Inhibitors (PPIs)

1.2.6 Pro-kinetic Agents

1.2.7 Others

1.3 Global Gastroesophageal Reflux Disease Therapeutics Market by Application

1.3.1 Overview: Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacy

1.3.3 Drug Stores

1.3.4 General Stores

1.3.5 Supermarkets

1.4 Global Gastroesophageal Reflux Disease Therapeutics Market Size & Forecast

1.5 Global Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast by Region

1.5.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Gastroesophageal Reflux Disease Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gastroesophageal Reflux Disease Therapeutics Market Drivers

1.6.2 Gastroesophageal Reflux Disease Therapeutics Market Restraints

1.6.3 Gastroesophageal Reflux Disease Therapeutics Trends Analysis

2 Company Profiles

2.1 AstraZeneca

2.1.1 AstraZeneca Details

2.1.2 AstraZeneca Major Business

2.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.1.4 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AstraZeneca Recent Developments and Future Plans

2.2 Eisai

2.2.1 Eisai Details

2.2.2 Eisai Major Business

2.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.2.4 Eisai Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Eisai Recent Developments and Future Plans

2.3 Takeda Pharmaceutical

2.3.1 Takeda Pharmaceutical Details

2.3.2 Takeda Pharmaceutical Major Business

2.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.3.4 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Takeda Pharmaceutical Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.4.4 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.5.4 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Johnson & Johnson Recent Developments and Future Plans

2.6 Daewoong Pharmaceutical

2.6.1 Daewoong Pharmaceutical Details

2.6.2 Daewoong Pharmaceutical Major Business

2.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.6.4 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Daewoong Pharmaceutical Recent Developments and Future Plans

2.7 Ironwood Pharmaceuticals

2.7.1 Ironwood Pharmaceuticals Details

2.7.2 Ironwood Pharmaceuticals Major Business

2.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.7.4 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Ironwood Pharmaceuticals Recent Developments and Future Plans

2.8 Rottapharm Madaus

2.8.1 Rottapharm Madaus Details

2.8.2 Rottapharm Madaus Major Business

2.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.8.4 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Rottapharm Madaus Recent Developments and Future Plans

2.9 Peer Medical

2.9.1 Peer Medical Details

2.9.2 Peer Medical Major Business

2.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.9.4 Peer Medical Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Peer Medical Recent Developments and Future Plans

2.10 Reviva Pharmaceuticals

2.10.1 Reviva Pharmaceuticals Details

2.10.2 Reviva Pharmaceuticals Major Business

2.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product and Solutions

2.10.4 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Reviva Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gastroesophageal Reflux Disease Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Gastroesophageal Reflux Disease Therapeutics Players Market Share

3.2.2 Top 10 Gastroesophageal Reflux Disease Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Gastroesophageal Reflux Disease Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gastroesophageal Reflux Disease Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Gastroesophageal Reflux Disease Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Gastroesophageal Reflux Disease Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2026)

6.2 North America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2026)

6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country

6.3.1 North America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2026)

7.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2026)

7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country

7.3.1 Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region

8.3.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Region (2016-2026)

8.3.2 China Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2026)

9.2 South America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2026)

9.3 South America Gastroesophageal Reflux Disease Therapeutics Market Size by Country

9.3.1 South America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country

10.3.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Gastroesophageal Reflux Disease Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca Major Business

Table 8. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 9. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Eisai Corporate Information, Head Office, and Major Competitors

Table 11. Eisai Major Business

Table 12. Eisai Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 13. Eisai Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 15. Takeda Pharmaceutical Major Business

Table 16. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 17. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline Major Business

Table 20. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 21. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson Major Business

Table 24. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 25. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Daewoong Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 27. Daewoong Pharmaceutical Major Business

Table 28. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 29. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Ironwood Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Ironwood Pharmaceuticals Major Business

Table 32. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 33. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Rottapharm Madaus Corporate Information, Head Office, and Major Competitors

Table 35. Rottapharm Madaus Major Business

Table 36. Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 37. Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Peer Medical Corporate Information, Head Office, and Major Competitors

Table 39. Peer Medical Major Business

Table 40. Peer Medical Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 41. Peer Medical Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Reviva Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Reviva Pharmaceuticals Major Business

Table 44. Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product and Solutions

Table 45. Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 47. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Players (2019-2021)

Table 48. Breakdown of Gastroesophageal Reflux Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Gastroesophageal Reflux Disease Therapeutics Players Head Office, Products and Services Provided

Table 50. Gastroesophageal Reflux Disease Therapeutics Mergers & Acquisitions in the Past Five Years

Table 51. Gastroesophageal Reflux Disease Therapeutics New Entrants and Expansion Plans

Table 52. Global Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 53. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Type (2016-2021)

Table 54. Global Gastroesophageal Reflux Disease Therapeutics Revenue Forecast by Type (2021-2026)

Table 55. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021)

Table 56. Global Gastroesophageal Reflux Disease Therapeutics Revenue Forecast by Application (2021-2026)

Table 57. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Gastroesophageal Reflux Disease Therapeutics Picture

Figure 2. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type in 2020

Figure 3. Antacids

Figure 4. H2 Receptor Blockers

Figure 5. Proton Pump Inhibitors (PPIs)

Figure 6. Pro-kinetic Agents

Figure 7. Others

Figure 8. Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application in 2020

Figure 9. Hospital Pharmacy Picture

Figure 10. Drug Stores Picture

Figure 11. General Stores Picture

Figure 12. Supermarkets Picture

Figure 13. Global Gastroesophageal Reflux Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Gastroesophageal Reflux Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region (2016-2026)

Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region in 2020

Figure 17. North America Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Gastroesophageal Reflux Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Gastroesophageal Reflux Disease Therapeutics Market Drivers

Figure 22. Gastroesophageal Reflux Disease Therapeutics Market Restraints

Figure 23. Gastroesophageal Reflux Disease Therapeutics Market Trends

Figure 24. AstraZeneca Recent Developments and Future Plans

Figure 25. Eisai Recent Developments and Future Plans

Figure 26. Takeda Pharmaceutical Recent Developments and Future Plans

Figure 27. GlaxoSmithKline Recent Developments and Future Plans

Figure 28. Johnson & Johnson Recent Developments and Future Plans

Figure 29. Daewoong Pharmaceutical Recent Developments and Future Plans

Figure 30. Ironwood Pharmaceuticals Recent Developments and Future Plans

Figure 31. Rottapharm Madaus Recent Developments and Future Plans

Figure 32. Peer Medical Recent Developments and Future Plans

Figure 33. Reviva Pharmaceuticals Recent Developments and Future Plans

Figure 35. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Players in 2020

Figure 36. Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in 2020

Figure 38. Global Top 10 Players Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Type in 2020

Figure 41. Global Gastroesophageal Reflux Disease Therapeutics Market Share Forecast by Type (2021-2026)

Figure 42. Global Gastroesophageal Reflux Disease Therapeutics Revenue Share by Application in 2020

Figure 43. Global Gastroesophageal Reflux Disease Therapeutics Market Share Forecast by Application (2021-2026)

Figure 44. North America Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type (2016-2026)

Figure 45. North America Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2016-2026)

Figure 46. North America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Country (2016-2026)

Figure 47. United States Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type (2016-2026)

Figure 51. Europe Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2016-2026)

Figure 52. Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Country (2016-2026)

Figure 53. Germany Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region (2016-2026)

Figure 61. China Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type (2016-2026)

Figure 68. South America Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2016-2026)

Figure 69. South America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz